| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |